In breast cancer, β‐catenin transcriptionally upregulates N‐glycosyltransferase STT3, which consequently mediates glycosylation of PD‐L1 and prevents PD‐L1 from ubiquitin/proteasome‐mediated degradation.56 Here, CD274 is linked to breast cancer.